Arvinas, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Arvinas, Inc. on August 19, 2022, covering events occurring on August 16 and August 18, 2022. The filing addresses changes to the Company's Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and director compensation.
Material Changes
- Director Resignation: Liam Ratcliffe resigned from the Board of Directors effective August 16, 2022. The resignation was not due to any disagreement regarding the Company's operations, policies, or practices.
- Director Election: John Young was elected as a Class II director effective August 18, 2022. He will serve until the 2023 annual meeting of stockholders.
- Committee Appointment: John Young was appointed to the Compensation Committee, which now consists of Timothy Shannon (Chair), Laurie Smaldone Alsup, and John Young.
Compensation and Indemnification
Mr. Young's compensatory arrangements include:
- Cash Compensation: $40,000 annual cash for director service plus $7,500 annual cash for Compensation Committee membership.
- Stock Option Grant: An option to purchase common stock with an aggregate grant date fair value of $750,000. The exercise price is $46.12 per share (closing price on August 18, 2022). The option vests monthly over three years.
- Indemnification: The Company entered into a standard indemnification agreement, potentially requiring the Company to cover expenses, judgments, fines, and settlements incurred by Mr. Young in connection with his service.
Outlook and Risks
The filing does not contain guidance, outlook, or management commentary on business operations. The primary risk disclosed relates to the potential financial obligation under the director indemnification agreement.
Key Facts for Investor Verification
- Confirm the effective dates of Liam Ratcliffe's resignation and John Young's election.
- Verify the vesting schedule and exercise price ($46.12) of the stock option granted to John Young.
- Review the composition of the Compensation Committee following the appointment.
- Check the Company's standard indemnification agreement terms filed as Exhibit 10.7 to the Form S-1.